NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
31 March 2025
| Name: | NEUREN PHARMACEUTICALS LIMITED (NEU) |
| ISIN: | NZNEUE0001S8 |
| Date of Listing: | 03 February 2005 |
Stock Exchange Status: (updated daily)
This entity is currently listed and quoted on the Australian Securities Exchange.Legal Status: (updated monthly)
ACN: 111 496 130ABN: 72 111 496 130
Registration Date: 22 October 2004
Capital Gains Tax (CGT) Status: (updated at least quarterly)
To crystallise a capital gain or capital loss on your securities in this entity, you are able to sell your securities on-market in the normal manner. If you determine that the market in your securities is illiquid and you still wish to crystallise a capital gain or loss, kindly contact deListed at admin@delisted.com.au for suggestions as to how you might proceed.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
Link Market Services Melbourne
Tower 4, 727 Collins Street Docklands VIC 3008
Tel : +61 3 9615 9800 or 61 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail
Expand this box to read and print
we understand that on or about this date the company consolidated its shares 1 for 20 | 29/11/2017 |
shares reinstated to quotation | 18/11/2009 |
the securities of Neuren Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to capital raising initiatives | 16/11/2009 |
the suspension of trading in the securities of Neuren Pharmaceuticals Limited (the "Company") will be lifted following the completion of its capital raising | 06/08/2008 |
company requests an extension to the voluntary suspension of the Company's securities from official quotation pending an announcement in relation to a proposed capital raising by Neuren - Neuren proposes that the voluntary suspension be lifted at the earlier of the announcement or the commencement of trading on 6 August 2008 | 04/08/2008 |
shares suspended from quotation pending an announcement about a capital raising | 31/07/2008 |
shares reinstated to quotation following receipt of an announcement providing details of the Company's capital raising | 02/12/2005 |
shares suspended from quotation pending an announcement about a capital raising | 01/12/2005 |
we understand that on or about this date the company consolidated its shares 1 for 20 | 29/11/2017 |
shares reinstated to quotation | 18/11/2009 |
the securities of Neuren Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to capital raising initiatives | 16/11/2009 |
the suspension of trading in the securities of Neuren Pharmaceuticals Limited (the "Company") will be lifted following the completion of its capital raising | 06/08/2008 |
company requests an extension to the voluntary suspension of the Company's securities from official quotation pending an announcement in relation to a proposed capital raising by Neuren - Neuren proposes that the voluntary suspension be lifted at the earlier of the announcement or the commencement of trading on 6 August 2008 | 04/08/2008 |
shares suspended from quotation pending an announcement about a capital raising | 31/07/2008 |
shares reinstated to quotation following receipt of an announcement providing details of the Company's capital raising | 02/12/2005 |
shares suspended from quotation pending an announcement about a capital raising | 01/12/2005 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 16/08/2024 | Joe Basile | 6,406 | $15.730 | $100,766 |
| 11/06/2024 | Joe Basile | 5,000 | $19.490 | $97,450 |
| 13/09/2023 | Joe Basile | 5,000 | $11.990 | $59,950 |
| 14/06/2023 | Trevor Scott | -1,175,000 | $13.000 | $15,275,000 |
| 18/10/2021 | Dianne Angus | 30,000 | $1.980 | $59,400 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Patrick Davies | Non Exec Chairman | 04/07/2018 |
| Jon Pilcher | Managing Director, CEO | 19/08/2013 |
| Lauren Frazer | CFO, Company Secretary | 01/08/2020 |
| Dianne Angus | Independent Director | 03/07/2018 |
| Joe Basile | Independent Director | 02/03/2023 |
| Trevor Scott | Non Exec Director | 05/03/2002 |
| Jenny Harry | Non Exec Director | 04/07/2018 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Richard Treagus | Executive Chairman | 31/01/2013 | 27/05/2020 |
| Larry Glass | Executive Director, CEO | 02/09/2013 | 31/12/2018 |
| Bruce Hancox | Non Exec Director | 08/03/2012 | 31/12/2017 |
| Rob Turnbull | CFO | 30/08/2013 | |
| John Holaday | Non Exec Director | 25/11/2009 | 30/08/2013 |
| Douglas Wilson | Non Exec Director | 17/06/2004 | 20/05/2013 |
| Robin Congreve | Director | 17/12/2001 | 20/05/2013 |
| Graeme Howie | Non Exec Director | 04/02/2005 | 31/05/2012 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
